Targeting heart failure with preserved ejection fraction: current status and future prospects

References

• SteinbergBAZhaoXHeidenreichPAGet With the Guidelines Scientific Advisory Committee and InvestigatorsTrends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomesCirculation20121261657522615345
   PubMed Web of Science ®Google Scholar
• SolomonSDAnavekarNSkaliHCandesartan in Heart Failure Reduction in Mortality (CHARM) InvestigatorsInfluence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patientsCirculation2005112243738374416330684
   PubMed Web of Science ®Google Scholar
• CampbellRTJhundPSCastagnoDHawkinsNMPetrieMCMcMurrayJJWhat have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?J Am Coll Cardiol201260232349235623141494
   PubMed Web of Science ®Google Scholar
• KawaguchiMHayIFeticsBKassDACombined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitationsCirculation2003107571472012578874
   PubMed Web of Science ®Google Scholar
• MelenovskyVBorlaugBARosenBCardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunctionJ Am Coll Cardiol200749219820717222731
   PubMed Web of Science ®Google Scholar
• KovacsAPappZNagyLCauses and pathophysiology of heart failure with preserved ejection fractionHeart Fail Clin201410338939824975903
   PubMed Web of Science ®Google Scholar
• PaulusWJTschopeCA novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammationJ Am Coll Cardiol201362426327123684677
   PubMed Web of Science ®Google Scholar
• BorbelyAvan der VeldenJPappZCardiomyocyte stiffness in diastolic heart failureCirculation2005111677478115699264
   PubMed Web of Science ®Google Scholar
• HidalgoCHudsonBBogomolovasJPKC phosphorylation of titin’s PEVK element: a novel and conserved pathway for modulating myocardial stiffnessCirc Res20091057631638 17 p following 63819679839
   PubMed Web of Science ®Google Scholar
• KrugerMKotterSGrutznerAProtein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springsCirc Res20091041879419023132
   PubMed Web of Science ®Google Scholar
• CampbellKSSorrellVLCell- and molecular-level mechanisms contributing to diastolic dysfunction in HFpEFJ Appl Physiol (1985)2015119101228123225911687
   PubMed Web of Science ®Google Scholar
• WeberKTBrillaCGJanickiJSMyocardial fibrosis: functional significance and regulatory factorsCardiovasc Res19932733413488490934
   PubMed Web of Science ®Google Scholar
• GuazziMSamajaMArenaRVicenziMGuazziMDLong-term use of sildenafil in the therapeutic management of heart failureJ Am Coll Cardiol200750222136214418036451
   PubMed Web of Science ®Google Scholar
• WeberTO’RourkeMFAmmerMKvasEPunzengruberCEberBArterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fractionAm J Hypertens200821111194120218787521
   PubMed Web of Science ®Google Scholar
• BorlaugBAKassDAVentricular-vascular interaction in heart failureCardiol Clin201129344745921803232
   PubMed Web of Science ®Google Scholar
• SchwartzenbergSRedfieldMMFromAMSorajjaPNishimuraRABorlaugBAEffects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapyJ Am Coll Cardiol201259544245122281246
   PubMed Web of Science ®Google Scholar
• BorlaugBAMelenovskyVRussellSDImpaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fractionCirculation2006114202138214717088459
   PubMed Web of Science ®Google Scholar
• BorlaugBALamCSRogerVLRodehefferRJRedfieldMMContractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fractionJ Am Coll Cardiol200954541041819628115
   PubMed Web of Science ®Google Scholar
• YuCMLinHYangHKongSLZhangQLeeSWProgression of systolic abnormalities in patients with “isolated” diastolic heart failure and diastolic dysfunctionCirculation2002105101195120111889013
   PubMed Web of Science ®Google Scholar
• Kraigher-KrainerEShahAMGuptaDKPARAMOUNT InvestigatorsImpaired systolic function by strain imaging in heart failure with preserved ejection fractionJ Am Coll Cardiol201463544745624184245
   PubMed Web of Science ®Google Scholar
• LamCSRogerVLRodehefferRJBorlaugBAEndersFTRedfieldMMPulmonary hypertension in heart failure with preserved ejection fraction: a community-based studyJ Am Coll Cardiol200953131119112619324256
   PubMed Web of Science ®Google Scholar
• TedfordRJHassounPMMathaiSCPulmonary capillary wedge pressure augments right ventricular pulsatile loadingCirculation2012125228929722131357
   PubMed Web of Science ®Google Scholar
• RobbinsIMHemnesARPughMEHigh prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertensionCirc Heart Fail20147111612224297689
   PubMed Web of Science ®Google Scholar
• BorlaugBAPaulusWJHeart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentEur Heart J201132667067921138935
   PubMed Web of Science ®Google Scholar
• PaulusWJTschopeCSandersonJEHow to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of CardiologyEur Heart J200728202539255017428822
   PubMed Web of Science ®Google Scholar
• KyBFrenchBMay KhanAVentricular-arterial coupling, remodeling, and prognosis in chronic heart failureJ Am Coll Cardiol201362131165117223770174
   PubMed Web of Science ®Google Scholar
• LangRMBadanoLPMor-AviVRecommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEur Heart J Cardiovasc Imaging201516323327025712077
   PubMed Web of Science ®Google Scholar
• ForfiaPRWatkinsSPRameJEStewartKJShapiroEPRelationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unitJ Am Coll Cardiol200545101667167115893185
   PubMed Web of Science ®Google Scholar
• KasnerMWestermannDSteendijkPUtility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization studyCirculation2007116663764717646587
   PubMed Web of Science ®Google Scholar
• FlachskampfFABiering-SorensenTSolomonSDDuvernoyOBjernerTSmisethOACardiac imaging to evaluate left ventricular diastolic functionJACC Cardiovasc Imaging2015891071109326381769
   PubMed Web of Science ®Google Scholar
• YancyCWJessupMBozkurtB2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesCirculation2013128161810185223741057
   PubMed Web of Science ®Google Scholar
• LindenfeldJAlbertNMBoehmerJPHFSA 2010 comprehensive heart failure practice guidelineJ Card Fail2010166e1e19420610207
   PubMed Web of Science ®Google Scholar
• McMurrayJJAdamopoulosSAnkerSDESC Committee for Practice GuidelinesESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEur J Heart Fail201214880386922828712
   PubMed Web of Science ®Google Scholar
• WrightJWMizutaniSHardingJWPathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategiesHeart Fail Rev200813336737517987382
   PubMed Web of Science ®Google Scholar
• ClelandJGTenderaMAdamusJPEP-CHF InvestigatorsThe perindopril in elderly people with chronic heart failure (PEP-CHF) studyEur Heart J200627192338234516963472
   PubMed Web of Science ®Google Scholar
• ZiMCarmichaelNLyeMThe effect of quinapril on functional status of elderly patients with diastolic heart failureCardiovasc Drugs Ther200317213313912975595
   PubMed Web of Science ®Google Scholar
• AronowWSKronzonIEffect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fractionAm J Cardiol19937176026048438750
   PubMed Web of Science ®Google Scholar
• YusufSPfefferMASwedbergKCHARM Investigators and CommitteesEffects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialLancet2003362938677778113678871
   PubMed Web of Science ®Google Scholar
• MassieBMCarsonPEMcMurrayJJI-PRESERVE InvestigatorsIrbesartan in patients with heart failure and preserved ejection fractionN Engl J Med2008359232456246719001508
   PubMed Web of Science ®Google Scholar
• WarnerJGJrMetzgerDCKitzmanDWWesleyDJLittleWCLosartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exerciseJ Am Coll Cardiol19993361567157210334425
   PubMed Web of Science ®Google Scholar
• ParthasarathyHKPieskeBWeisskopfMA randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fractionEur J Heart Fail2009111098098919789402
   PubMed Web of Science ®Google Scholar
• RoongsritongCSutthiwanPBradleyJSimoniJPowerSMeyerroseGESpironolactone improves diastolic function in the elderlyClin Cardiol2005281048448716274097
   PubMed Web of Science ®Google Scholar
• MottramPMHaluskaBLeanoRCowleyDStowasserMMarwickTHEffect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failureCirculation2004110555856515277317
   PubMed Web of Science ®Google Scholar
• MakGJLedwidgeMTWatsonCJNatural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenoneJ Am Coll Cardiol200954181674168219850207
   PubMed Web of Science ®Google Scholar
• EdelmannFWachterRSchmidtAGAldo-DHF InvestigatorsEffect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trialJAMA2013309878179123443441
   PubMed Web of Science ®Google Scholar
• PittBPfefferMAAssmannSFTOPCAT InvestigatorsSpironolactone for heart failure with preserved ejection fractionN Engl J Med2014370151383139224716680
   PubMed Web of Science ®Google Scholar
• SolomonSDZileMPieskeBProspective comparison of ARNI with ARB on Management Of heart failure with preserved ejection fraction (PARAMOUNT) InvestigatorsThe angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trialLancet201238098511387139522932717
   PubMed Web of Science ®Google Scholar
• AronowWSAhnCKronzonIEffect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitorsAm J Cardiol19978022072099230162
   PubMed Web of Science ®Google Scholar
• van VeldhuisenDJCohen-SolalABohmMSENIORS InvestigatorsBeta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (study of effects of nebivolol intervention on outcomes and rehospitalization in seniors with heart failure)J Am Coll Cardiol200953232150215819497441
   PubMed Web of Science ®Google Scholar
• YamamotoKOrigasaHHoriMInvestigatorsJDEffects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)Eur J Heart Fail201315111011822983988
   PubMed Web of Science ®Google Scholar
• PatelKFonarowGCEkundayoOJBeta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomesInt J Cardiol2014173339340124703206
   PubMed Web of Science ®Google Scholar
• BergstromAAnderssonBEdnerMNylanderEPerssonHDahlstromUEffect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC)Eur J Heart Fail20046445346115182771
   PubMed Web of Science ®Google Scholar
• NodariSMetraMDei CasLBeta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs nebivololEur J Heart Fail20035562162714607201
   PubMed Web of Science ®Google Scholar
• TakedaYFukutomiTSuzukiSEffects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fractionAm J Cardiol200494444845315325927
   PubMed Web of Science ®Google Scholar
• ConraadsVMMetraMKampOEffects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD studyEur J Heart Fail201214221922522147202
   PubMed Web of Science ®Google Scholar
• SetaroJFZaretBLSchulmanDSBlackHRSouferRUsefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performanceAm J Cardiol199066129819862220622
   PubMed Web of Science ®Google Scholar
• DavisBRKostisJBSimpsonLMALLHAT Collaborative Research GroupHeart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trialCirculation2008118222259226719001024
   PubMed Web of Science ®Google Scholar
• KanwarMAgarwalRBarnesMRole of phosphodiesterase-5 inhibitors in heart failure: emerging data and conceptsCurr Heart Fail Rep2013101263523114592
   PubMedGoogle Scholar
• RedfieldMMChenHHBorlaugBARELAX TrialEffect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialJAMA2013309121268127723478662
   PubMed Web of Science ®Google Scholar
• GuazziMPulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectivesCirc Heart Fail20147236737724643889
   PubMedGoogle Scholar
• HoendermisESLiuLCHummelYMEffects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trialEur Heart J201536382565257326188003
   PubMed Web of Science ®Google Scholar
• BondermanDPretschISteringer-MascherbauerRAcute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose studyChest201414651274128524991733
   PubMed Web of Science ®Google Scholar
• RedfieldMMAnstromKJLevineJANHLBI Heart Failure Clinical Research NetworkIsosorbide mononitrate in heart failure with preserved ejection fractionN Engl J Med20153732314232426549714
   PubMed Web of Science ®Google Scholar
• BorlaugBAKoeppKEMelenovskyVSodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fractionJ Am Coll Cardiol201566151672168226449137
   PubMed Web of Science ®Google Scholar
• ZamaniPRawatDShiva-KumarPEffect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fractionCirculation2015131437138025533966
   PubMed Web of Science ®Google Scholar
• AhmedARichMWFlegJLEffects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trialCirculation2006114539740316864724
   PubMed Web of Science ®Google Scholar
• MeyerPWhiteMMujibMDigoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failureAm J Cardiol2008102121681168619064024
   PubMed Web of Science ®Google Scholar
• MaierLSLayugBKarwatowska-ProkopczukERAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept studyJACC Heart Fail20131211512224621836
   PubMed Web of Science ®Google Scholar
• KosmalaWHollandDJRojekAWrightLPrzewlocka-KosmalaMMarwickTHEffect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trialJ Am Coll Cardiol201362151330133823916925
   PubMed Web of Science ®Google Scholar
• PalNSivaswamyNMahmodMEffect of selective heart rate slowing in heart failure with preserved ejection fractionCirculation2015132181719172526338956
   PubMed Web of Science ®Google Scholar
• FukutaHSaneDCBrucksSLittleWCStatin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary reportCirculation2005112335736316009792
   PubMed Web of Science ®Google Scholar
• ShahRWangYFoodyJMEffect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic functionAm J Cardiol2008101221722218178410
   PubMed Web of Science ®Google Scholar
• OuzounianMTuJVAustinPCChongALiuPPLeeDSStatin therapy and clinical outcomes in heart failure: a propensity-matched analysisJ Card Fail200915324124819327626
   PubMed Web of Science ®Google Scholar
• AlehagenUBensonLEdnerMDahlstromULundLHAssociation between use of statins and mortality in patients with heart failure and ejection fraction of >/=50Circ Heart Fail20158586287026243795
   PubMed Web of Science ®Google Scholar
• AbrahamWTAdamsonPBBourgeRCCHAMPION Trial Study GroupWireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trialLancet2011377976665866621315441
   PubMed Web of Science ®Google Scholar
• ButlerJFonarowGCZileMRDeveloping therapies for heart failure with preserved ejection fraction: current state and future directionsJACC Heart Fail2014229711224720916
   PubMed Web of Science ®Google Scholar